SEARCH

SEARCH BY CITATION

Cited in:

CrossRef

This article has been cited by:

  1. 1
    Joseph E. Burns, Jianhua Yao, Tatjana S. Wiese, Hector E. Muñoz, Elizabeth C. Jones, Ronald M. Summers, Automated Detection of Sclerotic Metastases in the Thoracolumbar Spine at CT, Radiology, 2013, 268, 1, 69

    CrossRef

  2. 2
    Arjun Muralidharan, Maree T. Smith, Pathobiology and management of prostate cancer-induced bone pain: recent insights and future treatments, Inflammopharmacology, 2013, 21, 5, 339

    CrossRef

  3. 3
    Geoffrey Burnstock, Timothy R. Arnett, Isabel R. Orriss, Purinergic signalling in the musculoskeletal system, Purinergic Signalling, 2013, 9, 4, 541

    CrossRef

  4. 4
    Fabiana N Soki, Serk In Park, Laurie K McCauley, The multifaceted actions of PTHrP in skeletal metastasis, Future Oncology, 2012, 8, 7, 803

    CrossRef

  5. 5
    Liliana Endo-Munoz, Andreas Evdokiou, Nicholas A. Saunders, The role of osteoclasts and tumour-associated macrophages in osteosarcoma metastasis, Biochimica et Biophysica Acta (BBA) - Reviews on Cancer, 2012, 1826, 2, 434

    CrossRef

  6. 6
    Gabri van der Pluijm, Cancer: Breast cancer bone metastases: denosumab or zoledronic acid?, Nature Reviews Endocrinology, 2011, 7, 3, 134

    CrossRef

  7. 7
    Roberta Faccio, Immune regulation of the tumor/bone vicious cycle, Annals of the New York Academy of Sciences, 2011, 1237, 1
  8. You have open access to this content8
    Hongchao Shan, Tetsuyuki Takahashi, Yoshimi Bando, Keisuke Izumi, Hisanori Uehara, Inhibitory effect of soluble platelet-derived growth factor receptor β on intraosseous growth of breast cancer cells in nude mice, Cancer Science, 2011, 102, 10
  9. 9
    Daniel Mendoza-Villanueva, Leo Zeef, Paul Shore, Metastatic breast cancer cells inhibit osteoblast differentiation through the Runx2/CBFβ-dependent expression of the Wnt antagonist, sclerostin, Breast Cancer Research, 2011, 13, 5, R106

    CrossRef

  10. 10
    Patricia Juárez, Theresa A. Guise, TGF-β in cancer and bone: Implications for treatment of bone metastases, Bone, 2011, 48, 1, 23

    CrossRef

  11. 11
    Matthew L. Broadhead, Jonathan C. M. Clark, Damian E. Myers, Crispin R. Dass, Peter F. M. Choong, The Molecular Pathogenesis of Osteosarcoma: A Review, Sarcoma, 2011, 2011, 1

    CrossRef

  12. 12
    Brendan F. Boyce, Lianping Xing, Edward M. Schwarz, Osteoimmunology, 2011,

    CrossRef

  13. 13
    J Rousseau, V Escriou, P Perrot, G Picarda, C Charrier, D Scherman, D Heymann, F Rédini, V Trichet, Advantages of bioluminescence imaging to follow siRNA or chemotherapeutic treatments in osteosarcoma preclinical models, Cancer Gene Therapy, 2010, 17, 6, 387

    CrossRef

  14. 14
    Denitsa Docheva, Daniela Padula, Matthias Schieker, Hauke Clausen-Schaumann, Effect of collagen I and fibronectin on the adhesion, elasticity and cytoskeletal organization of prostate cancer cells, Biochemical and Biophysical Research Communications, 2010, 402, 2, 361

    CrossRef

  15. 15
    Sandra Casimiro, Theresa A. Guise, John Chirgwin, The critical role of the bone microenvironment in cancer metastases, Molecular and Cellular Endocrinology, 2009, 310, 1-2, 71

    CrossRef

  16. 16
    JCM Clark, CR Dass, Peter FM Choong, Current and future treatments of bone metastases, Expert Opinion on Emerging Drugs, 2008, 13, 4, 609

    CrossRef

  17. 17
    Debu Tripathy, Highlights from: The 44th Annual Meeting of the American Society of Clinical Oncology; Chicago, IL; May 30-June 3, 2008, Clinical Breast Cancer, 2008, 8, 4, 313

    CrossRef